FDA is alerting consumers that Zicam Cold Remedy Nasal Gel, Zicam Cold Remedy Nasal Swabs, and Zicam Cold Remedy Swabs, Kids Size, a discontinued product that consumers may still have in their homes, have all been associated with long lasting or permanent loss of smell (referred to as anosmia). These products, marketed by Matrixx Initiatives, are zinc-containing, nasal cold remedies used to reduce the duration and severity of cold symptoms. However, these products have not been shown to be effective in the reduction of the duration and severity of cold symptoms.
This advisory does not concern oral zinc tablets and lozenges taken by mouth.
FDA recommends that consumers stop using these products and throw them away. See the FDA website for How to Dispose of Unused Medicines.
For treating symptoms of the common cold, consumers can take a number of other over-the-counter drugs. However, the common cold goes away without treatment, usually within seven to ten days.
Since the introduction of Zicam Cold Remedy Nasal Gel to the market in 1999, FDA has received more than 130 reports of anosmia associated with the use of Zicam zinc-containing intranasal products. The reports vary. Many people state that the loss of sense of smell occurred with the first dose of the Zicam product, although some people report it happened after later doses. The loss of sense of smell may be long-lasting or even permanent in some people.
Loss of the sense of smell may cause serious problems, such as failing to smell smoke, a gas leak, or spoiled food. Also, loss of the sense of smell is often linked with a loss of the sense of taste. People who cannot taste could unintentionally eat spoiled food and not appreciate flavors, and lose much of the pleasure of eating.
FDA recommends that consumers contact their healthcare provider if they experience loss of the sense of smell or taste, or experience other problems after using any zinc-containing nasal products.
Adverse reactions or quality problems experienced with the use of this Product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax, using the contact information at the bottom of this sheet.
Source: http://www.fda.gov/Drugs/DrugSafety/PublicHealthAdvisories/ucm166059.htm
Thursday, June 18, 2009
Wednesday, June 3, 2009
Swine Flu Now Reported in All 50 States
TUESDAY, June 2 (HealthDay News) -- Swine flu cases have now been reported in all 50 states, with the total number of people infected probably surpassing 200,000, U.S. health officials said Monday.
"It's accurate to say that there are probably several hundred thousand people that have been impacted by this flu," said Tom Skinner, a spokesman for the U.S. Centers for Disease Control and Prevention. "But that's in line with what we would see with seasonal influenza if we had the number of cases we are reporting right now."
And while the outbreak continues to wane, new cases will continue to emerge, Skinner said.
On Monday, the CDC was reporting a total of 10,053 cases in all 50 states and the District of Columbia, including 17 deaths. The agency has said in the past that confirmed cases of H1N1 swine flu represent about one in 20 of actual cases, bringing the total number of cases to about 200,000.
Infections with the H1N1 swine flu virus continue to be mild and recovery is fairly quick, as is the case with seasonal flu, officials said. Testing has found that the virus remains susceptible to two common antiviral drugs, Tamiflu and Relenza, according to the CDC.
What has been different about the swine flu outbreak, Skinner said, is that activity picked up late in the typical flu season. "What was unusual was that in late March into April and late May we saw activity at a higher-than-expected level," he said.
Dr. Anne Schuchat, the CDC's interim deputy director for science and public health program, said last week that the newly identified H1N1 swine flu virus continues to behave much like seasonal H1N1 viruses, which may partly explain why this flu strain affects more younger people. "Seasonal H1N1 often causes more disease in younger people, compared with the other strains that can be more common in older people," she said.
Some older people may have partial immunity to the H1N1 swine flu virus because of possible exposure to another H1N1 flu strain that circulated prior to 1957.
Schuchat said a vaccine for the swine flu virus could be ready in October, if research and testing proceed on pace this summer. Candidate viruses have been shipped to vaccine manufacturers, she said.
It's still not clear whether a swine flu vaccine is needed, Schuchat said. Any decision to move forward would be based on several factors, including the severity and spread of the virus and whether there's a safe and effective vaccine, she said.
During the next few months, scientists will be looking to see if the swine flu virus mutates or becomes resistant to antiviral medications, or is more easily spread among people, Schuchat said. The flu season is winding down in the Northern Hemisphere but is just beginning in the Southern Hemisphere.
Schuchat said there's no way to tell now if the H1N1 virus will be more virulent when -- and if -- it returns to the Northern Hemisphere with the approach of winter.
The World Health Organization said Monday that 53 countries have reported 15,510 cases of H1N1 swine flu, including 99 deaths, most of them in Mexico, where the outbreak began.
(story not over...scroll down a page)
U.S. Human Cases of H1N1 Flu Infection (As of June 1, 2009, 11:00 AM ET)
Source: U.S. Centers for Disease Control and Prevention
More information
For more on swine flu, visit the U.S. Centers for Disease Control and Prevention.
Found at: http://news.yahoo.com/s/hsn/20090602/hl_hsn/swineflunowreportedinall50states
"It's accurate to say that there are probably several hundred thousand people that have been impacted by this flu," said Tom Skinner, a spokesman for the U.S. Centers for Disease Control and Prevention. "But that's in line with what we would see with seasonal influenza if we had the number of cases we are reporting right now."
And while the outbreak continues to wane, new cases will continue to emerge, Skinner said.
On Monday, the CDC was reporting a total of 10,053 cases in all 50 states and the District of Columbia, including 17 deaths. The agency has said in the past that confirmed cases of H1N1 swine flu represent about one in 20 of actual cases, bringing the total number of cases to about 200,000.
Infections with the H1N1 swine flu virus continue to be mild and recovery is fairly quick, as is the case with seasonal flu, officials said. Testing has found that the virus remains susceptible to two common antiviral drugs, Tamiflu and Relenza, according to the CDC.
What has been different about the swine flu outbreak, Skinner said, is that activity picked up late in the typical flu season. "What was unusual was that in late March into April and late May we saw activity at a higher-than-expected level," he said.
Dr. Anne Schuchat, the CDC's interim deputy director for science and public health program, said last week that the newly identified H1N1 swine flu virus continues to behave much like seasonal H1N1 viruses, which may partly explain why this flu strain affects more younger people. "Seasonal H1N1 often causes more disease in younger people, compared with the other strains that can be more common in older people," she said.
Some older people may have partial immunity to the H1N1 swine flu virus because of possible exposure to another H1N1 flu strain that circulated prior to 1957.
Schuchat said a vaccine for the swine flu virus could be ready in October, if research and testing proceed on pace this summer. Candidate viruses have been shipped to vaccine manufacturers, she said.
It's still not clear whether a swine flu vaccine is needed, Schuchat said. Any decision to move forward would be based on several factors, including the severity and spread of the virus and whether there's a safe and effective vaccine, she said.
During the next few months, scientists will be looking to see if the swine flu virus mutates or becomes resistant to antiviral medications, or is more easily spread among people, Schuchat said. The flu season is winding down in the Northern Hemisphere but is just beginning in the Southern Hemisphere.
Schuchat said there's no way to tell now if the H1N1 virus will be more virulent when -- and if -- it returns to the Northern Hemisphere with the approach of winter.
The World Health Organization said Monday that 53 countries have reported 15,510 cases of H1N1 swine flu, including 99 deaths, most of them in Mexico, where the outbreak began.
(story not over...scroll down a page)
States | # confirmed/probable cases | Deaths |
Alabama | 84 | |
Alaska | 1 | |
Arkansas | 7 | |
Arizona | 547 | 4 deaths |
California | 804 | |
Colorado | 61 | |
Connecticut | 196 | |
Delaware | 121 | |
Florida | 166 | |
Georgia | 29 | |
Hawaii | 73 | |
Idaho | 13 | |
Illinois | 1103 | 3 deaths |
Indiana | 146 | |
Iowa | 71 | |
Kansas | 79 | |
Kentucky** | 77 | |
Louisiana | 122 | |
Maine | 11 | |
Maryland | 48 | |
Massachusetts | 470 | |
Michigan | 234 | |
Minnesota | 60 | |
Mississippi | 16 | |
Missouri | 36 | 1 death |
Montana | 14 | |
Nebraska | 43 | |
Nevada | 102 | |
New Hampshire | 40 | |
New Jersey | 74 | |
New Mexico | 108 | |
New York | 605 | 4 deaths |
North Carolina | 14 | |
North Dakota | 6 | |
Ohio | 23 | |
Oklahoma | 82 | |
Oregon | 148 | |
Pennsylvania | 123 | |
Rhode Island | 14 | |
South Carolina | 46 | |
South Dakota | 7 | |
Tennessee | 104 | |
Texas | 1403 | 3 deaths |
Utah | 247 | 1 death |
Vermont | 3 | |
Virginia | 31 | |
Washington | 575 | 1 death |
Washington, D.C. | 20 | |
West Virginia | 3 | |
Wisconsin | 1641 | |
Wyoming | 2 | |
TOTAL*(51) | 10,053 cases | 17 deaths |
*includes the District of Columbia **One case is resident of Ky. but hospitalized in Ga. |
Source: U.S. Centers for Disease Control and Prevention
More information
For more on swine flu, visit the U.S. Centers for Disease Control and Prevention.
Found at: http://news.yahoo.com/s/hsn/20090602/hl_hsn/swineflunowreportedinall50states
Subscribe to:
Posts (Atom)